Bioequivalence Study of DelanzoᵀᴹDR 60mg (Dexlansoprazole) Capsule With Dexilant® 60mg (Dexlansoprazole) Capsule in Healthy Pakistani Subjects.

Clinical trial NCT04877834 · COMPLETED

Trial details

NCT number: NCT04877834
Sponsor: University of Karachi
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Healthy Bioequivalence Study

Start date: 2021-09-18
Primary completion: 2022-10-25
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.